Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2019-03-05 Tx date 2019-03-01 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,633,775
+357,500 vol $4.57 each |
2,120,687 | |
Filed 2018-11-29 Tx date 2018-11-28 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$45,000
+25,000 vol $1.80 each |
||
Filed 2018-11-29 Tx date 2018-04-17 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,001
+27,007 vol $0.4444 each |
316,396 | |
Filed 2018-11-29 Tx date 2018-04-17 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,001.9108
-27,007 vol $0.4444 each |
1,818,187 | |
Filed 2018-11-29 Tx date 2018-11-28 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-45,000
-25,000 vol $1.80 each |
1,763,187 | |
Filed 2018-11-29 Tx date 2018-08-30 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-30,000 vol |
1,788,187 | |
Filed 2018-11-28 Tx date 2018-11-28 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$45,000
+25,000 vol $1.80 each |
314,389 | |
Filed 2018-11-28 Tx date 2018-11-28 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$45,000
+25,000 vol $1.80 each |
1,870,194 | |
Filed 2018-04-17 Tx date 2018-04-16 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,174,572
+418,187 vol $5.20 each |
1,845,194 | |
Filed 2017-04-03 Tx date 2017-03-24 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,417,500
+450,000 vol $3.15 each |
1,427,007 | |
Filed 2017-04-03 Tx date 2017-03-01 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-13,000
-5,000 vol $2.60 each |
0 | |
Filed 2016-06-21 Tx date 2016-06-16 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,750
+5,000 vol $3.35 each |
289,389 | |
Filed 2016-06-21 Tx date 2016-06-16 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-16,750
-5,000 vol $3.35 each |
5,000 | |
Filed 2016-03-29 Tx date 2016-03-15 |
$ABUS
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,773,000
+450,000 vol $3.94 each |
977,007 | |
Filed 2016-02-04 Tx date 2015-09-08 |
$TKMR
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-65,828.40
-219,428 vol $0.30 each |
||
Filed 2016-02-04 Tx date 2015-09-08 |
$TKMR
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-97,513.8032
-219,428 vol $0.4444 each |
527,007 | |
Filed 2015-12-23 Tx date 2015-03-30 |
$TKMR
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,162,600
+180,000 vol $17.57 each |
646,435 | |
Filed 2015-12-23 Tx date 2015-07-09 |
$TKMR
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,757,000
+100,000 vol $17.57 each |
746,435 | |
Filed 2015-12-23 Tx date 2015-09-08 |
$TKMR
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-65,828.40
-219,428 vol $0.30 each |
527,007 | |
Filed 2015-12-23 Tx date 2015-09-08 |
$TKMR
Arbutus Biopharma Corporation |
Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$97,513
+219,428 vol $0.4444 each |
284,389 |